BioSpace News Archive

Business

Thrive’s Blood Test IDs Cancers More than Twice That of Traditional Testing

The study was run by Johns Hopkins University and Geisinger Health, testing more than 10,000 women with no previous history of cancer.

April 29, 2020
·
3 min read
·
Mark Terry
Biotech Beach

Denovo Acquires Tocagen’s Gene Therapy Technology for Oncology

As Tocagen heads into its reverse merger with Forte Biosciences, Denovo Biopharma swooped in to snap up that company’s retroviral replicating vector platform (RRV), including an asset that stumbled in a Phase III study that Denovo believes still has some life.

April 29, 2020
·
2 min read
·
Alex Keown
Business

Almac Discovery and Merck Partner to Develop Inhibitors Against DUB Targets

Together, the companies will focus on the generation of novel small molecule inhibitors against specified deubiquitinase (DUB) targets, specifically for the treatment of neurodegenerative and other diseases.

April 29, 2020
·
3 min read
·
Krystle Vermes
FDA

FDA Approves New 6-Week Dosing for Keytruda for All Approved Adult Indications

The U.S. Food and Drug Administration approved an additional recommended dosage of 400 mg every six weeks for the anti-PD-1 therapy across all adult indications, including as a monotherapy and in combination treatments.

April 29, 2020
·
2 min read
·
Alex Keown
Policy

Following Ruling, Teva’s Cancer Drug Bendeka Protected From Generics Until 2031

Shares of Eagle Pharmaceuticals and Teva Pharmaceuticals are climbing following a favorable ruling in U.S. District Court that protects the patent for cancer drug Bendeka from generic competition through 2031.

April 29, 2020
·
2 min read
·
Alex Keown
Career Advice

How to Stay Connected with Coworkers While Doing Work from Home

Working from home has its perks, like no commute time and a more flexible schedule. But work from home can help you in keeping connections with co-workers difficult.

April 29, 2020
·
2 min read
·
Laura Brothers
Drug Development

Gilead Reports Positive Results from Two Trials of Remdesivir for COVID-19

Gilead announced topline results from the open-label, Phase III SIMPLE trial looking at 5-day and 10-day dosing of the drug in hospitalized patients with severe disease. It also reported positive data from the National Institute of Allergy and Infectious Diseases’ trial of the drug in COVID-19.

April 29, 2020
·
2 min read
·
Mark Terry
Business

Study Reveals Importance of Contact Tracing in COVID-19, Shows Men More Likely to Have Severe Infections

Recent reports revealed that the infection rates between adults and children were similar, but men are more likely to exhibit severe symptoms. The report also highlights the importance of contact tracing to help mitigate infection rates.

April 29, 2020
·
2 min read
·
Alex Keown
Drug Development

Biopharma Update on the Novel Coronavirus: April 29

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 29, 2020.

April 29, 2020
·
5 min read
·
BioSpace Editorial Staff
4 Work from Home Problems and How You Can Avoid Them

Despite external factors, there are things to maintain productivity while working remotely. Here are four common work from home problems and how you can avoid them!

April 29, 2020
·
3 min read
·
Porschia Parker-Griffin